High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis

M. H. Imam, E. Sinakos, A. A. Gossard, K. V. Kowdley, V. A.C. Luketic, M. Edwyn Harrison, T. McCashland, A. S. Befeler, D. Harnois, R. Jorgensen, J. Petz, J. Keach, A. C. Decook, F. Enders, K. D. Lindor

Research output: Contribution to journalArticle

61 Scopus citations

Fingerprint Dive into the research topics of 'High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis'. Together they form a unique fingerprint.

Medicine & Life Sciences